Conghua Xie

Wuhan University - Department of Radiation and Medical Oncology

169# Donghu Road

Wuhan

China

Leishenshan Hospital - Department of Medical Quality Control

Wuhan

China

SCHOLARLY PAPERS

4

DOWNLOADS

234

TOTAL CITATIONS

3

Scholarly Papers (4)

1.

Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients Undergoing Radiotherapy in Wuhan

Number of pages: 24 Posted: 31 Mar 2020
Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology and Duke-NUS Graduate Medical School Singapore
Downloads 139 (411,128)
Citation 2

Abstract:

Loading...

COVID-19; SARS-CoV-2; cancer; radiotherapy; infection control

2.

The Health Status of the Healthcare Workers from a Field Hospital (Leishenshan Hospital) During the Pandemic of COVID-19 in Wuhan, China

Number of pages: 13 Posted: 10 Jul 2020
Haijun Yu, Huili Chen, Chaoyan Wu, Lin Cai and Conghua Xie
Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Department of Traditional Chinese Medicine, Wuhan University - Department of Orthopedics and Wuhan University - Department of Radiation and Medical Oncology
Downloads 45 (794,156)

Abstract:

Loading...

COVID-19; healthcare workers; field hospital

3.

A Prognostic Risk Score Based on Integration of 9-Gene Expression and 5-Microbial Abundance Improves the Power to Predict Overall Survival of Patients with Cervical Squamous Carcinoma

Number of pages: 20 Posted: 26 Jul 2021
Wuhan University - Hubei Cancer Clinical Study Center, Wuhan University - Department of Pathology, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, University of California, Berkeley - Biological Systems and Engineering Division and Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors
Downloads 37 (854,172)

Abstract:

Loading...

cervical squamous cancer; prognosis; gene prognostic signature; microbiome prognostic signature; survival analysis

4.

Concurrent Chemoradiotherapy with Extended Nodal Irradiation and/or Erlotinib in Locally Advanced Esophageal Squamous Cell Cancer: Long-Term Follow-Up of a Randomized Phase 3 Trial

Number of pages: 64 Posted: 07 Jun 2019
Wenzhou Medical University - Second Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, The First People’s Hospital of Huaihua, Wenzhou Medical University - Taizhou Hospital of Zhejiang Province, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Bengbu Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital, Anhui Provincial Hospital, Wuhan University - Department of Radiation and Medical Oncology, Kaohsiung Medical University - Kaohsiung Medical University Hospital, Central Hospital of Lishui City, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Jiangsu Cancer Hospital, North Sichuan Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Information Center, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences - National Cancer Center and Hangzhou Cancer Hospital - Hangzhou Cancer Institute
Downloads 13 (1,094,506)
Citation 1

Abstract:

Loading...

esophageal squamous cell cancer, elective nodal irradiation, erlotinib